Surgivision files for IPO
MEMPHIS, TENNESSEE, January 6, 2010 - SurgiVision, Inc. announced that it has filed with the Securities and Exchange Commission a registration statement relating to the proposed initial public offering of shares of common stock. The filing provides for an offering of up to $30 million of common stock. All shares are being offered by SurgiVision through its underwriter, Rodman & Renshaw, LLC. SurgiVision intends to apply to the Nasdaq Capital Market to quote its common stock under the proposed trading symbol "SRGV".
A preliminary prospectus relating to these securities is not currently available. When available, a preliminary prospectus may be obtained from Rodman & Renshaw, LLC, 1251 Avenue of the Americas, New York, NY 10020 (telephone: 212.356.0500, fax: 212.581.5690, or Email: info@rodm.com).
* * *
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release is not an offer to sell nor does it seek an offer to buy in any jurisdiction where the offer or sale is not permitted.